| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.07 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.07 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.074 | 0.07 |